Objective: To compare the psychometric properties of the Calgary Depression Rating Scale (CDRS) and the Hamilton Depression Rating Scale (HDRS) for severity assessment of depression in acute schizophrenia.
D epressive signs and symptoms are highly prevalent during all illness states of schizophrenia (1) , and depression is often associated with a heightened risk for suicide, relapse or exacerbation, and lowered quality of life (2) .
After the advent of atypical antipsychotics, the optimism has increased that depressive symptoms could also become a target like positive and negative symptoms for more successful treatment of schizophrenia patients. Some data and recommendations corroborate this view (3, 4) , whereas results from several studies combining antidepressants and antipsychotics are still equivocal (5) . Despite the broad agreement among psychiatrists that depression in schizophrenia is associated with considerable clinical burden (6, 7) , there is no consensus regarding the best treatment strategy or clear indication for initiating specific treatment (8) . Thus the sensitive and specific assessment of depressive symptoms in schizophrenia is important for diagnostic, prognostic, and therapeutic reasons.
The most appropriate dimensional assessment instrument today is the CDRS (9-11), but the HDRS (12) , from which some modified items are also included in the CDRS (13) , is still widely used.
A score above 6 points on the CDRS has been proposed to separate schizophrenia patients with depression from those without depression (14) ; a further study has found optimal cut-off values of at least 7 points as related to major depression and CDRS scores of at least 4 points to detect minor depression in schizophrenia patients (15) . However, studies directly comparing the accuracy of the CDRS and the HDRS for separating clinically graded mild, moderate, and severe depression in schizophrenia are still lacking.
Methods
We investigated inpatients with stabilized acute schizophrenia diagnosed according to DSM-IV criteria. All patients gave their consent after the study procedure was fully explained.
The study was approved by the local ethics committee and is in full accordance with the German law.
Five experienced psychiatrists used the following tests during clinical routine: the semistructured, 9-item CDRS (9-11); the 17-item version of the HDRS (12); a global 4-point DEP-SEV (0 = no depression, 1 = mild, 2 = moderate, and 3 = severe depression); the PANSS (16); the severity item of the CGI (17) ; and other psychopathological scales not reported here. All raters had participated in continuous rater training. Intraclass correlation coefficients (5 raters and 20 schizophrenia patients) were $ 0.87 for CDRS, HDRS, and DEP-SEV ratings, indicating high interrater reliability. We assessed global severity of depression according to DSM-IV criteria of a major depressive episode with the following modifications: severity of depression was rated independently of psychotic features, and the time frame was set to 1 week. Means, SDs, and the correlation of depression scores are reported. We applied ROCs to evaluate and compare the diagnostic accuracy of the CDRS and HDRS sum scores, using global severity ratings as categorical criterion. We estimated AUC and standard errors, as well as sensitivity and specificity with corresponding 95%CIs (18) , and statistically compared them between CDRS and HDRS scores (19) . Nonoverlapping 95%CIs were regarded as statistically significant (P < 0.05).
Results
We investigated 119 inpatients (38% women and 71% paranoid subtype) with a mean age of 31.9 years, SD 10.7. Age at onset of schizophrenia was 26.8 years, SD 7.6; the inpatient treatment duration at the time of assessment was 19.3 days, SD 11.1. All patients were under neuroleptic treatment (72% atypical), and 28% received an antidepressant (19% a mood stabilizer, 11% anticholinergic drugs, and 55% benzodiazepines) at the time of assessment. Mean PANSS total score was 77 points, SD 22; PANSS positive symptoms, 18 points, SD 8; and PANSS negative syndrome, 21 points, SD 8. The CGI severity score was 4.0 points, SD 1.3. Mean scores of depression assessment were as follows: CDRS 6.4, SD 5.8; HDRS 14.8, SD 8.7; and DEP-SEV 1.4, SD 1.1 points. The global assessment of depression severity ratings revealed that 31% of patients had no depression, 19% had mild depression, 31% had moderate depression, and 19% had severe depression. The distribution of CDRS and HDRS scores is shown in Figure 1 , together with severity gradations.
For the severity categories of depression (mild, moderate, and severe), the means and 95%CIs of CDRS and HDRS are shown in Figure 2 .
Generally, nonoverlapping CIs were yielded for CDRS, but not for HDRS, scores (only mild, compared with moderate, scores). 
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HDRS scores were significantly correlated with CDRS scores (r = 0.78, P < 0.001), and both depression scales were significantly associated with DEP-SEV scores (CDRS r = 0.80, P < 0.001; HDRS r = 0.82, P < 0.001). Table 1 and Figure 3 show results of ROC analyses.
Sensitivity ($ 0.76) and specificity ($ 0.88) were sufficiently high for both scales across all severity categories. Slight but statistically significant (P < 0.05) superiority emerged in favour of the CDRS for the assessment of at least mild depression and severe depression. When the conventional HDRS cut-off value for severe depression of 25 points was applied, sensitivity dropped to 0.63 (specificity 0.96).
Discussion
This naturalistic clinical study replicated earlier findings that a large proportion of acute schizophrenia patients show signs and symptoms of depression with substantial severity along with coexisting positive, negative, and other schizophrenia symptoms. In the present study, we used a pragmatic global assessment of depression severity, partly following the DSM-IV criteria for major depression as a reference and comparable to the global assessment of illness severity on the CGI scale (17) , which has become a worldwide standard. Nevertheless, this may be criticized because global and specific assessments of depression were carried out by the same rater and because the psychometric qualities of the reference assessment itself can be questioned. However, the lack of an established gold standard for the severity gradation of depression is also pertinent for studies in major depression (20, 21) .
Although both depression scales were correlated and highly effective in separating mild, moderate, and severe depression, significant advantages emerged in favour of the CDRS. Use of the HDRS with conventional cut-off scores does not seem fully appropriate when applied to patients with schizophrenia. Thus the CDRS should be used with the presented cut-off values, particularly for a sensitive detection of mild (for example, subthreshold) depression at an early stage or to assess schizophrenia patients with severe depression who require thorough follow-up assessment and specific interventions (1,7). Méthode : Durant un traitement clinique régulier, nous avons interrogé 119 patients hospitalisés souffrant de schizophrénie aiguë, à l'aide de la CDRS, de l'HDRS et d'une échelle de la gravité générale de la dépression en 4 points (DEP-SEV). Nous avons comparé les scores totaux à la CDRS et à l'HDRS, à l'égard de l'exactitude diagnostique, en utilisant le critère de la gravité générale de la dépression. Nous avons estimé la sensibilité et la spécificité en fonction des courbes caractéristiques actuelles du récepteur.
Résultats : Selon l'évaluation clinique générale (DEP-SEV), 31 % des patients n'avaient « aucune dépression », 19 % avaient une « légère dépression », 31 % avaient une « dépression modérée » et 19 % avaient une « dépression grave ». La sensibilité était significativement plus élevée (P < 0,05) pour la CDRS que l'HDRS pour évaluer la dépression légère (0,94 comparé avec 0,76, seuil d'inclusion 3 et 10 points, respectivement) ou la dépression grave (1,00 comparé avec 0,78, seuil d'inclusion 11 et 22 points, respectivement); la spécificité était comparativement élevée (³ 0,88) pour les deux échelles.
Conclusion :
Malgré le fait que les deux échelles étaient efficaces pour distinguer la dépression légère, modérée et grave, la CDRS a démontré des avantages significatifs pour détecter la dépression légère ou grave dans la schizophrénie.
